NDC 0409-6535-11 - Vancomycin Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-6535
- Requested NDC
- 0409-6535-11
- Package NDCs from labels
- 0409-6535-11, 0409-6535-01
- Manufacturer
- Hospira, Inc.
- Effective date
- 2026-05-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Vancomycin Hydrochloride for Injection, USP | Hospira, Inc. | 2026-05-18 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-6535-01 | Vancomycin Hydrochloride | 10 in 1 TRAY | INJECTION, POWDER, LYOPHILIZED, | 10 | 35 | |
| 0409-6535-11 | Vancomycin Hydrochloride | 1 in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, LYOPHILIZED, | 1 | 35 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-6535-01 | EA - Each | 0409-6535 | c7d4942f-c291-403f-841f-9c738da63abf | 1 | 2012-07-24 |
| 0409-6535-11 | EA - Each | 0409-6535 | 4696696d-e777-4e1f-b3be-4cd64cee32d5 | 1 | 2019-11-12 |
| 0409-6535-49 | EA - Each | 0409-6535 | aa102e81-9cf7-459b-b4b1-0aef29da8f84 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| VANCOMYCIN HYDROCHLORIDE | ACTIVE INGREDIENT | 71WO621TJD | VANCOMYCIN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] | 18 | |
| VANCOMYCIN | ACTIVE MOIETY | 6Q205EH1VU | VANCOMYCIN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] | 18 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | VANCOMYCIN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] | 18 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | VANCOMYCIN HYDROCHLORIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [HOSPIRA, INC.] | 18 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Cameron Pharmaceuticals | bc737938-ae36-460b-a2a8-609f3fe59156 | 2026-08-17 | Warnings, Adverse reactions | 71WO621TJD |
| vancomycin hydrochloride | VANCOMYCIN HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 127d95d1-8070-41ac-8343-3168b0cf1312 | 2026-08-05 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Avenacy, LLC | c757e65b-ca6f-4c00-afe2-025962b43d31 | 2026-07-31 | Warnings, Adverse reactions | 2049890 1807518 71WO621TJD |
| vancomycin hydrochloride | VANCOMYCIN HYDROCHLORIDE | Redpharm Drug | 57d23aed-a3f7-f92e-e063-6394a90add7d | 2026-07-30 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Hospira, Inc. | b01aaa02-8f1d-4b57-96a5-337503428af1 | 2026-07-20 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Meitheal Pharmaceuticals Inc. | 033efc76-11d5-4a93-91de-56ed41bab9c3 | 2026-07-08 | Warnings, Adverse reactions | 1807513 1807516 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Bryant Ranch Prepack | 7bbd2c81-33d9-4397-8795-8b9fa28cb5cf | 2026-06-26 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Bryant Ranch Prepack | d6b8147b-5f93-49ee-8b27-78fe58987c90 | 2026-06-26 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Bryant Ranch Prepack | 28fe3c01-cf87-41c0-87fd-f93a40524335 | 2026-06-16 | Warnings, Adverse reactions | 71WO621TJD |
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | Total Operations Management LLC DBA:Bestmade Natural Products Micro | 5423bde6-3e31-38b0-e063-6294a90afb2d | 2026-06-13 | Warnings | QTT17582CB |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Eurofarma, Inc. | 826510bd-b611-42d9-a574-ec7ee4151ef5 | 2026-06-12 | Warnings, Adverse reactions | 1807513 1807516 71WO621TJD |
| BM BM182 DROPS | HEPAR SULF, GRAPHITES, MERC SOL, MURIATIC ACID | BM Private Limited | 540d11e3-e4a1-0ca2-e063-6394a90a3c26 | 2026-06-12 | Warnings | QTT17582CB |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Bryant Ranch Prepack | 6c74b360-022a-4c4d-9e4b-0988219a78fb | 2026-06-12 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Bryant Ranch Prepack | 8193f588-a032-451e-a0a1-819a5ea834c8 | 2026-06-12 | Warnings, Adverse reactions | 71WO621TJD |
| VANCOMYCIN HYDROCHLORIDE | VANCOMYCIN HYDROCHLORIDE | Baxter Healthcare Corporation | 99e523d8-9bde-43cb-8434-497015e5dcbd | 2026-06-09 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Bryant Ranch Prepack | a09c589b-e7f4-457c-827f-e1bfa1b26700 | 2026-05-26 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Bryant Ranch Prepack | 786bde33-9aec-4b4d-ba46-90bfd61956d0 | 2026-05-26 | Warnings, Adverse reactions | 71WO621TJD |
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Bryant Ranch Prepack | 9b6a7a21-4fde-40c6-a420-a8546a4dc701 | 2026-05-26 | Warnings, Adverse reactions | 71WO621TJD |
| Muriaticum acidum | HYDROCHLORIC ACID | Boiron | 8643bc58-bb0e-5c79-e053-2991aa0a02ae | 2026-05-19 | Warnings | QTT17582CB |
| 6fc26ccd-fdf0-4522-9c7c-d3be55a784bb | 2fd9de3f-a95f-451c-a687-d2e1306e53bf | 2026-05-18 | Warnings, Adverse reactions | 6fc26ccd-fdf0-4522-9c7c-d3be55a784bb 2fd9de3f-a95f-451c-a687-d2e1306e53bf |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.